re: News: Biotron's Hep C drug candidate phas... Very, very exciting prospect here IMO (for the hearing impaired)
Dr.Michelle Miller CEO
"regulatory authorities such as the FDA in the US have been really clear in saying they are very keen to see trials quickly, and development through the market quickly, in difficult to treat hepatitis C populations and one of those groups is the HIV and HCV co-infected populations. Up to 30% of HIV patients are also are also infected with Hep C".
"Biotron is in the unique position of having this drug BIT-225 which has activity against both HIV and Hepatitis C".
Bring on the deal/s !!!
Cheers,
FF
- Forums
- ASX - By Stock
- BIT
- News: Biotron's Hep C drug candidate phase 2a tri
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

News: Biotron's Hep C drug candidate phase 2a tri, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $1.606K | 803.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
58 | 39950557 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 17911809 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
58 | 39950557 | 0.002 |
34 | 68141001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 17911809 | 22 |
0.004 | 12820969 | 17 |
0.005 | 6690600 | 5 |
0.006 | 1200000 | 2 |
0.007 | 484188 | 1 |
Last trade - 14.19pm 01/07/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online